Advertisement

Topics

NuCana Company Profile

16:37 EDT 24th June 2018 | BioPortfolio

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide technology has the potential to set new benchmarks in efficacy and safety with its treatments that are specifically designed to overcome key cancer resistance mechanisms. Acelarin® is NuCana’s lead medicine and was the first ProTide to enter the clinic in October 2010. Acelarin achieved exceptional levels of disease control in a broad range of patients with advanced, rapidly progressing solid tumours. Global Phase III studies with Acelarin are currently being planned in ovarian, biliary and pancreatic cancers. Privately held, NuCana, which raised $57 million in a Series B financing in April 2014, is backed by world-leading investors including Sofinnova Partners, Sofinnova Ventures, Morningside Ventures, Alida Capital International and the Scottish Investment Bank.


News Articles [14 Associated News Articles listed on BioPortfolio]

NuCana plc: NuCana Announces Appointment of Cyrille Leperlier to its Board of Directors

EDINBURGH, United Kingdom, May 21, 2018 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer pa...

NuCana plc: NuCana Reports First Quarter 2018 Financial Results

EDINBURGH, United Kingdom, May 23, 2018 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer pa...

NuCana: Buy The Dip

NuCana raises US$114m in IPO of ADSs

NuCana gains on first-line biliary cancer readout

NuCana reports Phase Ib data for Acelarin in first-line biliary cancer

NuCana wins at this year's Life Sciences Awards gala in Glasgow

TRXC Up 100% This Month, XTNT Gets FDA Nod, FMI Building Solid Foundation

NuCana plc (NCNA) has appointed Cyrille Leperlier to its Board as an independent non-executive Director.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

NuCana

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide...

More Information about "NuCana" on BioPortfolio

We have published hundreds of NuCana news stories on BioPortfolio along with dozens of NuCana Clinical Trials and PubMed Articles about NuCana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NuCana Companies in our database. You can also find out about relevant NuCana Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record